Skip to main navigation Skip to search Skip to main content

Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?

Research output: Contribution to journalArticlepeer-review

Abstract

This review discusses the available evidence concerning the use of anticholinergic drugs, alone or in combination with α-adrenoceptor antagonists, in men with lower urinary tract symptoms due to benign prostatic hyperplasia, benign prostatic enlargement, or benign prostatic obstruction and concomitant overactive bladder syndrome. We emphasize the safety and efficacy of anticholinergic agents in treating men with benign prostatic obstruction. Several recent studies of men with an overactive bladder suggest that combination therapy of anticholinergic and α-adrenoceptor antagonists improves the symptoms effectively without increasing the incidence of acute urinary retention.

Original languageEnglish
Pages (from-to)491-501
Number of pages11
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume377
Issue number4-6
DOIs
StatePublished - Jun 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bladder
  • Cholinergic antagonists
  • Neurogenic
  • Prostatic hyperplasia

Fingerprint

Dive into the research topics of 'Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?'. Together they form a unique fingerprint.

Cite this